Schistosoma mansoni Tegument Protein Sm29 Is Able to Induce a Th1-Type of Immune Response and Protection against Parasite Infection


Autoria(s): CARDOSO, Fernanda C.; MACEDO, Gilson C.; GAVA, Elisandra; KITTEN, Gregory T.; MATI, Vitor L.; MELO, Alan L. de; CALIARI, Marcelo V.; ALMEIDA, Giulliana T.; VENANCIO, Thiago M.; VERJOVSKI-ALMEIDA, Sergio; OLIVEIRA, Sergio C.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/04/2012

19/04/2012

2008

Resumo

Background: Schistosomiasis continues to be a significant public health problem. This disease affects 200 million people worldwide and almost 800 million people are at risk of acquiring the infection. Although vaccine development against this disease has experienced more failures than successes, encouraging results have recently been obtained using membrane-spanning protein antigens from the tegument of Schistosoma mansoni. Our group recently identified Sm29, another antigen that is present at the adult worm tegument surface. In this study, we investigated murine cellular immune responses to recombinant (r) Sm29 and tested this protein as a vaccine candidate. Methods and Findings: We first show that Sm29 is located on the surface of adult worms and lung-stage schistosomula through confocal microscopy. Next, immunization of mice with rSm29 engendered 51%, 60% and 50% reduction in adult worm burdens, in intestinal eggs and in liver granuloma counts, respectively (p<0.05). Protective immunity in mice was associated with high titers of specific anti-Sm29 IgG1 and IgG2a and elevated production of IFN-gamma, TNF-alpha and IL-12, a typical Th1 response. Gene expression analysis of worms recovered from rSm29 vaccinated mice relative to worms from control mice revealed a significant (q<0.01) down-regulation of 495 genes and up-regulation of only 22 genes. Among down-regulated genes, many of them encode surface antigens and proteins associated with immune signals, suggesting that under immune attack schistosomes reduce the expression of critical surface proteins. Conclusion: This study demonstrates that Sm29 surface protein is a new vaccine candidate against schistosomiasis and suggests that Sm29 vaccination associated with other protective critical surface antigens is the next logical strategy for improving protection.

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)

Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG)

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)

FINEP/SEBRAE

Identificador

PLOS NEGLECTED TROPICAL DISEASES, v.2, n.10, 2008

1935-2735

http://producao.usp.br/handle/BDPI/16749

10.1371/journal.pntd.0000308

http://dx.doi.org/10.1371/journal.pntd.0000308

Idioma(s)

eng

Publicador

PUBLIC LIBRARY SCIENCE

Relação

Plos Neglected Tropical Diseases

Direitos

openAccess

Copyright PUBLIC LIBRARY SCIENCE

Palavras-Chave #ACID-BINDING PROTEIN #INTERFERON-GAMMA #DNA VACCINE #IFN-GAMMA #MICE #SURFACE #IMMUNIZATION #GENE #TRANSCRIPTOME #METAANALYSIS #Infectious Diseases #Parasitology #Tropical Medicine
Tipo

article

original article

publishedVersion